191 related articles for article (PubMed ID: 10049760)
1. Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells.
Nakamura T; Oka M; Aizawa K; Soda H; Fukuda M; Terashi K; Ikeda K; Mizuta Y; Noguchi Y; Kimura Y; Tsuruo T; Kohno S
Biochem Biophys Res Commun; 1999 Feb; 255(3):618-24. PubMed ID: 10049760
[TBL] [Abstract][Full Text] [Related]
2. A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene.
Narasaki F; Oka M; Fukuda M; Nakano R; Ikeda K; Takatani H; Terashi K; Soda H; Yano O; Nakamura T; Doyle LA; Tsuruo T; Kohno S
Cancer Chemother Pharmacol; 1997; 40(5):425-32. PubMed ID: 9272120
[TBL] [Abstract][Full Text] [Related]
3. MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs.
Giaccone G; van Ark-Otte J; Rubio GJ; Gazdar AF; Broxterman HJ; Dingemans AM; Flens MJ; Scheper RJ; Pinedo HM
Int J Cancer; 1996 Jun; 66(6):760-7. PubMed ID: 8647646
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
Germann UA; Ford PJ; Shlyakhter D; Mason VS; Harding MW
Anticancer Drugs; 1997 Feb; 8(2):141-55. PubMed ID: 9073310
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
6. Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance.
Naito S; Koike K; Ono M; Machida T; Tasaka S; Kiue A; Koga H; Kumazawa J
Oncol Res; 1998; 10(3):123-32. PubMed ID: 9700723
[TBL] [Abstract][Full Text] [Related]
7. Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells.
Berger W; Hauptmann E; Elbling L; Vetterlein M; Kokoschka EM; Micksche M
Int J Cancer; 1997 Mar; 71(1):108-15. PubMed ID: 9096673
[TBL] [Abstract][Full Text] [Related]
8. A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein.
Nakano R; Oka M; Nakamura T; Fukuda M; Kawabata S; Terashi K; Tsukamoto K; Noguchi Y; Soda H; Kohno S
Biochem Biophys Res Commun; 1998 Oct; 251(1):307-12. PubMed ID: 9790952
[TBL] [Abstract][Full Text] [Related]
9. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Kim HS; Min YD; Choi CH
Biochem Biophys Res Commun; 2001 Apr; 283(1):64-71. PubMed ID: 11322768
[TBL] [Abstract][Full Text] [Related]
10. Reversal of drug resistance mediated by multidrug resistance protein (MRP) 1 by dual effects of agosterol A on MRP1 function.
Chen ZS; Aoki S; Komatsu M; Ueda K; Sumizawa T; Furukawa T; Okumura H; Ren XQ; Belinsky MG; Lee K; Kruh GD; Kobayashi M; Akiyama S
Int J Cancer; 2001 Jul; 93(1):107-13. PubMed ID: 11391629
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells.
Narasaki F; Oka M; Fukuda M; Ikeda K; Terashi K; Takatani H; Nakamura T; Soda H; Kohno S
Anticancer Res; 1997; 17(5A):3493-7. PubMed ID: 9413193
[TBL] [Abstract][Full Text] [Related]
12. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F
Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209
[TBL] [Abstract][Full Text] [Related]
13. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.
Loe DW; Almquist KC; Deeley RG; Cole SP
J Biol Chem; 1996 Apr; 271(16):9675-82. PubMed ID: 8621643
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells.
Stride BD; Grant CE; Loe DW; Hipfner DR; Cole SP; Deeley RG
Mol Pharmacol; 1997 Sep; 52(3):344-53. PubMed ID: 9281595
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
Essodaigui M; Broxterman HJ; Garnier-Suillerot A
Biochemistry; 1998 Feb; 37(8):2243-50. PubMed ID: 9485370
[TBL] [Abstract][Full Text] [Related]
18. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
19. The relationship between modulation of MDR and glutathione in MRP-overexpressing human leukemia cells.
Grech KV; Davey RA; Davey MW
Biochem Pharmacol; 1998 Apr; 55(8):1283-9. PubMed ID: 9719484
[TBL] [Abstract][Full Text] [Related]
20. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.
Paul S; Breuninger LM; Tew KD; Shen H; Kruh GD
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6929-34. PubMed ID: 8692921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]